460 related articles for article (PubMed ID: 25736722)
1. Inhibition of Acetylcholinesterase (AChE): A Potential Therapeutic Target to Treat Alzheimer's Disease.
Li Y; Zhang XX; Jiang LJ; Yuan L; Cao TT; Li X; Dong L; Li Y; Yin SF
Chem Biol Drug Des; 2015 Oct; 86(4):776-82. PubMed ID: 25736722
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of icariin on acetylcholinesterase].
Zhang YD; Cai YN; Zhang Q; Qi ZL; Gao QQ
Yao Xue Xue Bao; 2012 Sep; 47(9):1141-6. PubMed ID: 23227542
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
Li RS; Wang XB; Hu XJ; Kong LY
Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
[TBL] [Abstract][Full Text] [Related]
5. Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro.
Guo AJ; Xie HQ; Choi RC; Zheng KY; Bi CW; Xu SL; Dong TT; Tsim KW
Chem Biol Interact; 2010 Sep; 187(1-3):246-8. PubMed ID: 20452337
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
Liu S; Shang R; Shi L; Zhou R; He J; Wan DC
Chem Biol Drug Des; 2014 Aug; 84(2):169-74. PubMed ID: 24890706
[TBL] [Abstract][Full Text] [Related]
8. Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease.
Kuppusamy A; Arumugam M; George S
Int J Biol Macromol; 2017 Feb; 95():199-203. PubMed ID: 27871793
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives.
Liu H; Fan H; Gao X; Huang X; Liu X; Liu L; Zhou C; Tang J; Wang Q; Liu W
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):580-9. PubMed ID: 26186269
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids as acetylcholinesterase inhibitors.
Uriarte-Pueyo I; Calvo MI
Curr Med Chem; 2011; 18(34):5289-302. PubMed ID: 22087826
[TBL] [Abstract][Full Text] [Related]
11. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and acetylcholinesterase inhibitory activity of Mannich base derivatives flavokawain B.
Liu HR; Huang XQ; Lou DH; Liu XJ; Liu WK; Wang QA
Bioorg Med Chem Lett; 2014 Oct; 24(19):4749-4753. PubMed ID: 25205193
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of dual acetylcholinesterase and phosphodiesterase 5A inhibitors in treatment for Alzheimer's disease.
Zhou LY; Zhu Y; Jiang YR; Zhao XJ; Guo D
Bioorg Med Chem Lett; 2017 Sep; 27(17):4180-4184. PubMed ID: 28751142
[TBL] [Abstract][Full Text] [Related]
14. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents.
Luo W; Wang T; Hong C; Yang YC; Chen Y; Cen J; Xie SQ; Wang CJ
Eur J Med Chem; 2016 Oct; 122():17-26. PubMed ID: 27343850
[TBL] [Abstract][Full Text] [Related]
16. Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations.
Singh M; Kaur M; Singh N; Silakari O
Bioorg Med Chem; 2017 Dec; 25(24):6273-6285. PubMed ID: 29089261
[TBL] [Abstract][Full Text] [Related]
17. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
18. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
Rehman TU; Khan IU; Ashraf M; Tarazi H; Riaz S; Yar M
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28220522
[TBL] [Abstract][Full Text] [Related]
19. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer's disease: A review.
Jiang Y; Gao H; Turdu G
Bioorg Chem; 2017 Dec; 75():50-61. PubMed ID: 28915465
[TBL] [Abstract][Full Text] [Related]
20. Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors.
Baharloo F; Moslemin MH; Nadri H; Asadipour A; Mahdavi M; Emami S; Firoozpour L; Mohebat R; Shafiee A; Foroumadi A
Eur J Med Chem; 2015 Mar; 93():196-201. PubMed ID: 25681712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
